Home  Feedback  Career  Sitemap  Contact Us
 
Market Buzz
Corporate Info
Market Analysis
Movers
Corporate Action
Other Markets
IPO
 
Sun Pharmaceuticals Industries Ltd
  Sun Pharmaceuticals Industries allots 1,314 equity shares | [24-May-2018]
  Sun Pharmaceuticals Industries Ltd - Board Meeting-Outcome of Committee Meeting | [24-May-2018]
  Sun Pharma receives USFDA approval for YONSA┬« (abiraterone acetate) | [23-May-2018]
  Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release | [23-May-2018]
  Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release | [23-May-2018]
  Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 | [19-May-2018]
  Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 | [19-May-2018]
  Sun Pharma launches Authorized Generic version of Welchol┬« Tablets | [18-May-2018]
  Sun Pharma gains after launch of generic Welchol tablets in US | [18-May-2018]
  Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Financial Results Updates | [18-May-2018]
  Sun Pharmaceuticals Industries Ltd - Exercise Of Option To Submit Consolidated Financial Results As Per Regulation 33(3)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | [17-May-2018]
  Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release | [17-May-2018]
  Sun Pharmaceuticals Industries to conduct board meeting | [11-May-2018]
  Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release | [11-May-2018]
  Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release | [11-May-2018]
Back Top
Source:Capital Market

Member Code : NCDEX - 00241 | MCX - 31435
SEBI Regn. Nos : BSE INB010643030 | NSE(EQ) INB230643037 | NSE(FUT) INF230643037 FOR INVESTORS GRIEVANCE : complaints@cilsecurities.com
FOR DP GRIEVANCE : grievance@cilsecurities.com
Privacy Policy  |  Disclaimer | BrokerNorms |  BSE Complaints
Useful Links :  NSE | BSE  | CDSL | MCX  | NCDEX | SEBI | RBI
Designed , Developed & Powered By C-MOTS Infotech
(ISO 9001:2015 certified)